Table 1. Prognostic value of TSA-deregulated genes in primary MMC of newly diagnosed patients.

Probe set	Name	Adjusted P-value (Benjamini–Hochberg multiple testing correction)	Hazard ratio
Bad prognostic genes
204563_at	SELL	0.04	1.94
203567_s_at	TRIM38	0.04	1.96
201012_at	ANXA1	0.02	2.01
205352_at	SERPINI1	0.04	2.03
204944_at	PTPRG	0.01	2.12
222651_s_at	TRPS1	0.03	2.17
214875_x_at	APLP2	0.01	2.19
203854_at	IF	0.03	2.34
209958_s_at	PTHB1	0.01	2.35
209969_s_at	STAT1	0.009	2.37
205552_s_at	OAS1	0.01	2.50
226269_at	GDAP1	0.008	2.69
210432_s_at	SCN3A	0.007	2.71
224701_at	PARP14	0.01	2.94
214079_at	DHRS2	4.76e−05	3.11
226158_at	KLHL24	0.01	3.44
Good prognostic genes
34408_at	RTN2	2.42e−05	0.28
225842_at	—	9.96e−05	0.32
208894_at	HLA-DRA	0.01	0.36
212464_s_at	FN1	0.01	0.37
202391_at	BASP1	7.01e−05	0.37
228726_at	SERPINB1	0.009	0.38
235301_at	KIAA1324L	0.01	0.39
206385_s_at	ANK3	0.007	0.40
230233_at	RASGEF1B	0.04	0.42
215193_x_at	HLA-DRB1	0.01	0.43
212636_at	QKI	0.02	0.44
212998_x_at	HLA-DQB1	0.01	0.47
223218_s_at	NFKBIZ	0.03	0.47
209198_s_at	SYT11	0.03	0.48
211990_at	HLA-DPA1	0.02	0.49
218918_at	MAN1C1	0.04	0.49
215388_s_at	CFH	0.04	0.52
228152_s_at	FLJ31033	0.03	0.53
216834_at	RGS1	0.04	0.54
203695_s_at	DFNA5	0.04	0.54
219833_s_at	EFHC1	0.04	0.55

Abbreviations: TSA=trichostatin A; MMC=multiple myeloma cell.